Adam R. Craig - Jun 30, 2021 Form 4 Insider Report for CTI BIOPHARMA CORP (CTIC)

Role
President and CEO, Director
Signature
Adam R. Craig
Stock symbol
CTIC
Transactions as of
Jun 30, 2021
Transactions value $
$15,962
Form type
4
Date filed
12/2/2021, 04:16 PM
Next filing
Mar 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTIC common stock Award $10.6K +5K +100% $2.13* 10K Jun 30, 2021 Direct F1
transaction CTIC common stock Purchase $2.02K +1.32K +13.22% $1.52* 11.3K Dec 2, 2021 Direct
transaction CTIC common stock Purchase $3.32K +2.18K +19.24% $1.53* 13.5K Dec 2, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.